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Background
Adrenaline is the first-line emergency treatment for ana-
phylaxis. The only adrenaline auto-injector (AAI) cur-
rently available in Portugal is Anapen®. The aim of this
study was to evaluate adrenaline prescription in the
Emergency Department (ED) and the patients’ capacity
to correctly simulate adrenaline administration.
Methods
Patients with food allergy (FA) and hymenoptera venom
allergy (HVA) followed in our department were invited
to simulate adrenaline administration with an Anapen®
trainer and a medical record review was performed.
Results
A total of 36 individuals (50% male, mean age 34.5
years) were included; 28 with HVA (26 on venom
immunotherapy) and 8 with FA. Twenty-seven went to
an ED. Adrenaline was administered in only 3 and just5
of them were discharged with an AAI prescription. The
remaining 22 had their AAI prescribed and taught how
to use it, only after consultation with an Allergist.
Twenty-three (64%) had their Anapen® with them and
19 (53%) admitted carrying it on a daily basis. Fourteen
(39%) performed the simulation correctly, although 7 of
them did not massage the injection site, as instructed by
the manufacturer. On average, 2 training sessions were
performed per patient but, despite this, 22 (61%) failed
at various steps, including 4 who injected with the
wrong end. Six reported using their Anapen® in a real
life situation, but curiously 4 of them did not simulate
the administration effectively.
Comments
According to the WAO guidelines, patients with ana-
phylaxis history should carry an AAI. Adrenaline under-
use and a deficient prescription of adrenaline (14%) on
discharge from the ED as well in non-specialized centres
was evident. Approximately two thirds of our patients
failed to demonstrate proper administration, regardless
of previous patient education. This is an unacceptably
high proportion of at risk patients. This device requires
repeated and regular training sessions since this is the
only AAI available in Portugal. Adrenaline is potentially
lifesaving if the patient is willing to use it and is capable
of injecting it correctly. Practice makes perfect.
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